For best experience please turn on javascript and use a modern browser!
Bekijk de site in het Nederlands

Invasive therapies, especially the implantable cardioverter-defibrillator (ICD) have become important treatment options for patients with inherited cardiac arrhythmia syndromes who are at risk of sudden cardiac death (SCD). Louise Olde Nordkamp provides evidence for the optimization of the benefit-harm equilibrium of treatment in patients with inherited cardiac arrhythmia syndromes, evaluating current treatment strategies and testing new treatment options which aim to minimise therapy harm.

Event details of Invasive therapy for cardiac arrhythmia syndromes
Date 30 January 2015
Time 10:00 -11:00
Location Agnietenkapel

L.R.A. Olde Nordkamp, Invasive Therapy for Inherited Cardiac Arrhythmias: Towards a better Benefit-Risk Equilibrium.

Supervisor

Prof. A.A.M. Wilde

Co-supervisors

Dr J.R. de Groot
Dr N. van Dijk

Agnietenkapel

Oudezijds Voorburgwal 229 - 231
1012 EZ Amsterdam

Entrance

This event is open to the public.